AssetMark Inc
HRMY icon

AssetMark Inc’s Harmony Biosciences HRMY Stock Holding History

AssetMark Inc’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48K Hold
68
– – ﹤0.01% 2905
2026
Q1 		$1.91K Buy
68
+12
+21% +$393 ﹤0.01% 2870
2025
Q4 		$2.1K Sell
56
-23
-29% -$756 ﹤0.01% 2764
2025
Q3 		$2.18K Buy
79
+23
+41% +$792 ﹤0.01% 2607
2025
Q2 		$1.77K Buy
56
+19
+51% +$611 ﹤0.01% 2468
2025
Q1 		$1.23K Hold
37
– – ﹤0.01% 2264
2024
Q4 		$1.27K Buy
37
+5
+16% +$172 ﹤0.01% 2195
2024
Q3 		$1.28K Hold
32
– – ﹤0.01% 1952
2024
Q2 		$965 Hold
32
– – ﹤0.01% 1853
2024
Q1 		$1.07K Sell
32
-7
-18% -$225 ﹤0.01% 1665
2023
Q4 		$1.26K Buy
+39
New +$1.09K ﹤0.01% 1604

Other funds holding HRMY

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AssetMark Inc's HRMY Position: Q2 2026 in Review

AssetMark Inc held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 68 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

AssetMark Inc first reported a position in HRMY in Q4 2023 and has held it in 11 quarters since. 96 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • AssetMark Inc held 68 shares of Harmony Biosciences worth $2.48K as of Q2 2026.
  • AssetMark Inc left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2905 holding.
  • AssetMark Inc first reported a position in Harmony Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 96 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.